Status:
ACTIVE_NOT_RECRUITING
Explorative Proteomics in Pediatric Neuroborreliosis
Lead Sponsor:
Rigshospitalet, Denmark
Collaborating Sponsors:
Clinical Proteomics, Department of Clinical Biochemistry, Bispebjerg Hospital
NNF Center for Protein Research, University of Copenhagen
Conditions:
Neuroborreliosis
Facial Palsy
Eligibility:
All Genders
1-17 years
Brief Summary
This study aims to use proteomic analysis to diagnose Lyme Neuroborreliosis (LNB) in children. Pediatric patients with suspected LNB will be enrolled, and their blood samples will be collected for pro...
Detailed Description
Objective: The primary objective of this study is to investigate the utility of proteomic analysis in diagnosing lyme neuroborreliosis (LNB) in children. By identifying specific protein markers assoc...
Eligibility Criteria
Inclusion
- Presenting at a pediatric ward with facial nerve palsy and/or suspicion of lyme neuroborreliosis
- Parental informed consent
Exclusion
- Parents or legal guardians unable to understand given information or comply with study criteria
- Patient unable to cooperate to study procedures (blood sample)
- Unclear etiology after lumbar puncture
Key Trial Info
Start Date :
October 17 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 10 2024
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT06579235
Start Date
October 17 2019
End Date
December 10 2024
Last Update
September 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Department of Children and Adolescents
Copenhagen, Denmark, 2100